RP

Roger Perlmutter

Chairman, President, and CEO

Eikon Therapeutics

Hayward, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Eikon Therapeutics
Industry
research
Employees
400.0
Seniority
C suite
Annual Revenue
5600000.0
Total Funding
1122500000.0
Latest Funding
Series D

Professional Summary

Roger Perlmutter serves as Chairman, President, and CEO at Eikon Therapeutics. Eikon Therapeutics operates in the research sector with approximately 400.0 employees. The company is headquartered in Hayward, California. Eikon Therapeutics generates annual revenue of 5600000.0. To date, Eikon Therapeutics has raised 1122500000.0 in total funding, with the most recent round being Series D.

Industry & Role Insights

  • MessageCEO tracks 2,961 executives in the research sector.
  • We have verified contacts for 3 executives at Eikon Therapeutics.
  • 13,743 executive contacts are available in California.
  • Our database includes 201,469 c suite-level executives.

Technologies

Amazon SES Outlook Atlassian Cloud Greenhouse.io Webflow WordPress.org Google Maps Google Font API Jobvite Google Tag Manager Mobile Friendly Remote AI

Keywords

biotechnology research biotechnology drug discovery advanced engineering clinical development therapeutic pipeline solid tumors immunology neuroscience molecular biology preclinical programs high-throughput single-molecule tracking pharmacokinetics biomarkers serious diseases targeted therapies oncology research teams drug development cellular mechanisms innovative therapeutics real-time imaging drug interaction therapeutic modalities scientific research cell dynamics cancer therapies clinical programs engineered solutions precision medicine safety reporting healthcare conference nimble operations molecule screening protein dynamics drug targets patient-centric technology integration data analysis high-throughput strategies clinical research drug evaluation translational research target engagement biopharmaceuticals scientific innovation cell biology genetic research drug formulation safety assessments super-resolution microscopy single molecule tracking tlr7/8 agonist parp1 inhibitors live-cell imaging automation high-performance computing clinical trials advanced drug development healthcare providers pharmaceutical companies research institutions global presence diverse expertise breakthrough therapeutics patient outcomes cancer treatment advanced technologies drug development ecosystem investors strategic partnerships hospital & health care data analytics health care health wellness & fitness

Related Executives

BH
Barbara Howes Executive Vice President & Chief People Officer at Eikon Therapeutics
MK
Michael Klobuchar Chief Operating Officer at Eikon Therapeutics
SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands

Frequently Asked Questions

How can I contact Roger Perlmutter?

Roger Perlmutter's verified email address is available on MessageCEO. They currently work at Eikon Therapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Roger Perlmutter lead?

Roger Perlmutter is Chairman, President, and CEO at Eikon Therapeutics, a company in the research sector with 400.0 employees. The company is based in Hayward, California.

What industry is Roger Perlmutter in?

Roger Perlmutter works in the research industry as Chairman, President, and CEO at Eikon Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Roger Perlmutter's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Roger Perlmutter's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: April 11, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans